I understand but that wasn't the gist of my post.
Post# of 30027
Actually, company originally stated P2 trials to commence in 3rd quarter of 2015
http://www.amarantus.com/news/press-releases/...versity-in
Quote:
Amarantus is developing ESS for the treatment of severe burns and is preparing to commence Phase 2 clinical studies in the third quarter of 2015.
As I stated, delays are understandable in biotech but a pattern of false claims is not.